- Report
- May 2024
- 200 Pages
Global
From €3799EUR$4,150USD£3,229GBP
- Report
- March 2024
- 200 Pages
Global
From €3799EUR$4,150USD£3,229GBP
- Report
- October 2023
- 145 Pages
Global
From €2884EUR$3,150USD£2,451GBP
- Report
- November 2023
- 189 Pages
Global
From €4119EUR$4,500USD£3,501GBP
- Report
- October 2023
- 175 Pages
Global
From €4119EUR$4,500USD£3,501GBP
- Report
- February 2024
- 112 Pages
Global
From €4348EUR$4,750USD£3,695GBP
- Report
- June 2023
- 204 Pages
Global
From €3295EUR$3,600USD£2,801GBP
- Report
- August 2024
- 84 Pages
Global
From €3500EUR$4,096USD£3,079GBP
- Report
- February 2024
- 92 Pages
Global
From €3500EUR$4,096USD£3,079GBP
- Report
- May 2025
- 50 Pages
Global
From €2426EUR$2,650USD£2,062GBP
- Report
- August 2022
- 324 Pages
Global
From €2461EUR$2,688USD£2,091GBP
€3515EUR$3,840USD£2,987GBP
Naloxone is a medication used to reverse the effects of opioid overdose. It is a life-saving drug used to treat opioid addiction and overdoses. Naloxone works by blocking the effects of opioids on the brain, allowing the person to regain consciousness and breathe normally. It is available in both injectable and nasal spray forms, and is often used in emergency situations.
Naloxone is an important part of the treatment of opioid addiction and overdose. It is used in hospitals, clinics, and other healthcare settings, as well as by first responders and law enforcement. It is also available over-the-counter in many states, allowing individuals to have access to the drug in case of an emergency.
Naloxone is a critical tool in the fight against opioid addiction and overdose. It is used to save lives and to help individuals recover from opioid addiction.
Some companies in the Naloxone market include Adapt Pharma, Kaléo, and Amphastar Pharmaceuticals. Show Less Read more